These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10979402)
1. [Primary breast tumor and malignant phyllodes tumor of the breast-- two rare cases demonstrated by technetium 99m scintimammography]. Pappo I; Horne T; Merdad H; Orda R Harefuah; 2000 Jun; 138(11):932-5, 1007. PubMed ID: 10979402 [TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors. Ohta H; Komibuchi T; Nishio T; Kitai T; Yamamoto S; Ukikusa M; Awane H; Irie K; Shintaku M Ann Nucl Med; 1997 Feb; 11(1):37-9. PubMed ID: 9095321 [TBL] [Abstract][Full Text] [Related]
3. Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report. Papantoniou V; Koutsikos J; Sotiropoulou M; Mainta E; Lazaris D; Tsiouris S; Zerva C Jpn J Clin Oncol; 2004 Jul; 34(7):429-31. PubMed ID: 15342672 [TBL] [Abstract][Full Text] [Related]
4. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions. Lam WW; Yang WT; Chan YL; Stewart IE; King W; Metreweli C Br J Radiol; 1996 Dec; 69(828):1152-8. PubMed ID: 9135472 [TBL] [Abstract][Full Text] [Related]
5. Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast. Ohta H; Yamamoto S; Ukikusa M; Awane H; Shintaku M; Irie K Clin Nucl Med; 1997 Aug; 22(8):553-4. PubMed ID: 9262903 [No Abstract] [Full Text] [Related]
6. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166 [TBL] [Abstract][Full Text] [Related]
7. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts]. Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110 [TBL] [Abstract][Full Text] [Related]
8. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer? Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742 [TBL] [Abstract][Full Text] [Related]
10. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450 [TBL] [Abstract][Full Text] [Related]
11. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer. Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206 [TBL] [Abstract][Full Text] [Related]
13. The role of Tc99m-sestamibi scintimammography in combination with the triple assessment of primary breast cancer. Leidenius MH; Leppänen EA; Tykkä HT; von Smitten KA Eur J Surg Oncol; 2002 Mar; 28(2):108-12. PubMed ID: 11884044 [TBL] [Abstract][Full Text] [Related]
14. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography. Scopinaro F; Ierardi M; Porfiri LM; Tiberio NS; De Vincentis G; Mezi S; Cannas P; Gigliotti T; Marzetti L Anticancer Res; 1997; 17(3B):1635-8. PubMed ID: 9179209 [TBL] [Abstract][Full Text] [Related]
15. New method for breast cancer detection using TC-99m sestamibi scintimammography. Yuen-Green M; Wasnich R; Caindec-Ranchez S; Davis J Hawaii Med J; 1996 Feb; 55(2):26-8. PubMed ID: 8820628 [TBL] [Abstract][Full Text] [Related]
16. Tc-99m MIBI in suspected recurrent breast cancer. Cwikla JB; Kolasinska A; Buscombe JR; Hilson AJ Cancer Biother Radiopharm; 2000 Aug; 15(4):367-72. PubMed ID: 11041021 [TBL] [Abstract][Full Text] [Related]
17. A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Scopinaro F; Schillaci O; Ussof W; Nordling K; Capoferro R; De Vincentis G; Danieli R; Ierardi M; Picardi V; Tavolaro R; Colella AC Anticancer Res; 1997; 17(3B):1631-4. PubMed ID: 9179208 [TBL] [Abstract][Full Text] [Related]
19. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases]. Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570 [TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]